MESTINON

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MESTINON contains one active pharmaceutical ingredient (API):

1 Pyridostigmine
UNII KVI301NA53 - PYRIDOSTIGMINE BROMIDE

Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine.

Read about Pyridostigmine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MESTINON Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N07AA02 Pyridostigmine N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1959D, 2608G, 2724J
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 541718030017817
Country: CA Health Products and Food Branch Identifier(s): 00869953, 00869961
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 4865-MEE-1119, 4870-MEE-1119
Country: EE Ravimiamet Identifier(s): 1480564, 1664625, 1664647
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 23524
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 173898, 173948
Country: FR Base de données publique des médicaments Identifier(s): 67013510, 68333755
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 185923, 199693, 24834, 373649
Country: HK Department of Health Drug Office Identifier(s): 03376, 03386, 58081
Country: IE Health Products Regulatory Authority Identifier(s): 33855, 36700
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 334
Country: JP 医薬品医療機器総合機構 Identifier(s): 1239003F1046
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004557
Country: MT Medicines Authority Identifier(s): MA1507/01401, PI565/78601A, PI729/27301A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 44564, 530M2002
Country: NL Z-Index G-Standaard, PRK Identifier(s): 6203, 6211
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10009
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100116797, 100442189
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68713001, W68713002, W68713003
Country: SG Health Sciences Authority Identifier(s): 02898P, 03214P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8698856120021
Country: US FDA, National Drug Code Identifier(s): 0187-3010, 0187-3012, 0187-3013
Country: ZA Health Products Regulatory Authority Identifier(s): C/5.3/610, UX/5.3/179

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.